Cidara Therapeutics, Inc. — Director's Dealing 2024

Apr 30, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2024-04-26

Reporting Person: Spencer Ryan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-26	Stock Option (right to buy)	$12.63	A	4250	Acquired	2034-04-25	Common Stock (4250)	Direct

Footnotes

F1: 1/3rd of the total number of shares subject to the award shall vest on April 26, 2025 and the remaining 2/3rds of the shares will vest in equal monthly installments over a two year period such that the option is fully vested on April 26, 2027.